(Q39077970)

8 September 2017

title

Tailored doxorubicin-hyaluronan conjugate as a potent anticancer glyco-drug: an alternative to prodrug approach (English)

1 reference

8 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Javad Garousi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Oommen P. Varghese

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Marije Sloff

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

15 October 2013

1 reference

Macromolecular Bioscience

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

327-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24130147%20AND%20SRC:MED&resulttype=core&format=json

Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Synthesis, characterization, antitumor activity of pluronic mimicking copolymer micelles conjugated with doxorubicin via acid-cleavable linkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Reversible covalent chemistry in drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Modular approach to functional hyaluronic acid hydrogels using orthogonal chemical reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Synthesis of guanidinium-modified hyaluronic Acid hydrogel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

CD44: from adhesion molecules to signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Bone reservoir: Injectable hyaluronic acid hydrogel for minimal invasive bone augmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

CD44 protein levels and its biological activity are regulated in Balb/c 3T3 fibroblasts by serum factors and by transformation with the ras but not with the sis oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201300383